{"References": [{"title": "Natural killer cells for cancer immunotherapy: a new CAR is catching up", "authors": "Evren Alici, Tolga Sutlu, Biljana Björkstrand, Mari Gilljam, Barbara Stellan, Hans Nahi, Hareth Nahi, Hernan Concha, Gösta Gahrton, Hans-Gustaf Ljunggren, Björn Önfelt, M. Sirac Dilber", "journal": "Seminars in Immunology", "year": "2015", "volumes": "27", "first page": "64", "last page": "75", "DOI": "10.1016/j.smim.2015.03.002"}, {"title": "Engaging natural killer cells in cancer immunotherapy", "authors": "Michele Ardolino, Camillia Azimi, Alexandre Iannello, Troy N. Trevino, Lucas Horan, Lily Zhang, Weiwen Deng, Aaron M. Ring, Suzanne Fischer, Kevin C. Garcia, David H. Raulet", "journal": "Immunity", "year": "2014", "volumes": "40", "first page": "785", "last page": "797", "DOI": "10.1016/j.immuni.2014.04.008"}, {"title": "Designing NK cell-based immunotherapies for cancer", "authors": "Sandro Matosevic", "journal": "Nature Biomedical Engineering", "year": "2022", "volumes": "6", "first page": "1024", "last page": "1037", "DOI": "10.1038/s41551-022-00949-4"}, {"title": "CAR T Cells: Driving the Road from the Laboratory to the Clinic", "authors": "Carl H. June, Roddy S. O'Connor, Omkar U. Kawalekar, Saba Ghassemi, Michael C. Milone", "journal": "Immunity", "year": "2018", "volumes": "49", "first page": "38", "last page": "48", "DOI": "10.1016/j.immuni.2018.07.005"}, {"title": "Strategies to enhance NK cell function for the treatment of tumors and infections", "authors": "Amir Horowitz, Katharine C. Behrens, Tobias M. Zweig, Domenico Mavilio, Jeffrey S. Miller", "journal": "Immunity", "year": "2021", "volumes": "54", "first page": "646", "last page": "658", "DOI": "10.1016/j.immuni.2021.03.002"}, {"title": "Engineering T Cells for Cancer Therapy", "authors": "Yvonne Y. Chen, Yanyan Li", "journal": "Annual Review of Biomedical Engineering", "year": "2016", "volumes": "18", "first page": "405", "last page": "430", "DOI": "10.1146/annurev-bioeng-082515-022035"}, {"title": "Harnessing the power of innate lymphoid cells in cancer immunotherapy", "authors": "Lorenzo Moretta, Emanuela Marcenaro, Simona Sivori, Michela Della Chiesa, Mariella Vitale, Alessandro Moretta", "journal": "Cell Research", "year": "2014", "volumes": "24", "first page": "1280", "last page": "1291", "DOI": "10.1038/cr.2014.123"}, {"title": "Targeting natural killer cells in cancer immunotherapy", "authors": "Estrella Mariel Levy, Mariana Paula Roberti, José Mordoh", "journal": "Expert Opinion on Biological Therapy", "year": "2014", "volumes": "14", "first page": "905", "last page": "915", "DOI": "10.1517/14712598.2014.895811"}, {"title": "Engineered T cells: the promise and challenges of cancer immunotherapy", "authors": "Michel Sadelain, Isabelle Rivière, Stanley Riddell", "journal": "Nature Reviews Cancer", "year": "2017", "volumes": "17", "first page": "97", "last page": "109", "DOI": "10.1038/nrc.2016.97"}, {"title": "Natural killer cells in cancer immunotherapy", "authors": "Andreas Lundqvist, Jeroen H. F. Falkenburg, Karl-Johan Malmberg", "journal": "Annual Review of Immunology", "year": "2020", "volumes": "38", "first page": "505", "last page": "528", "DOI": "10.1146/annurev-immunol-082619-045206"}]}